Established 2016|Australia's longest-standing research supplier|Trusted by 4,000+ researchers & labs|Batch-tested · Fast AU-wide dispatch
VCP Australia
Sign In
Peptides — Growth Hormone Axis

GHRP-2

Growth-Hormone-Releasing Peptide 2, a synthetic hexapeptide ghrelin-receptor agonist studied as a GH-release tool in pre-clinical pharmacology.

Education Hub

Pre-clinical mechanism

Selective agonist at the ghrelin/GHS-R1a receptor, eliciting pulsatile GH release in animal and human pharmacology studies.

Key pre-clinical findings

  • Children with GH deficiency phase-1/2 pharmacology: dose-dependent GH release after acute administration (Bowers, 1998).

Primary literature

Growth hormone-releasing peptides — structure and kinetics

Bowers CY · Journal of Pediatric Endocrinology & Metabolism · 1993

Research and educational use only. This page summarises publicly available pre-clinical literature for educational and scientific reference. It is not medical, clinical, dosing or therapeutic advice. Nothing on this page implies that any VCP Australia product is approved, certified, safe, effective, suitable for a particular purpose, or intended for human or animal consumption.

Research-Use Notice

Products displayed on this website may be intended for laboratory, analytical or research purposes only where applicable. They are not intended to diagnose, treat, cure or prevent any disease. They are not supplied for human or animal consumption unless expressly stated and lawfully permitted. Customers are responsible for understanding and complying with all applicable laws and regulations. Product information is provided for informational purposes only and does not constitute medical advice.

Read Full Disclaimer